I find it interesting to note that J&J sent their notification out to Canadian professionals last October but is only now alerting the US community.
Recall as well that Risperdal is being used with an increasing number of children, which is off-label both in it’s application and in use with juveniles (no studies have been completed to date for pediatric use).
http://www.heartcenteronline.com/myheartdr/home/research-detail.cfm?reutersid=3524&nl=4
Apr 14 (Reuters) - Johnson & Johnson on Thursday said it will soon send letters to thousands of US physicians advising them of possible increased risk of stroke among elderly patients taking its blockbuster antipsychotic drug Risperdal.
A J&J spokeswoman told Reuters the company also plans to change the package insert label of the pill, which has annual global sales of $2.1 billion, to note the possible stroke risk.
Dad,
Thank you so much for this post. I have a friend who takes this drug and I am going to let her know about this information.
PT